Your browser doesn't support javascript.
loading
Mutational topography reflects clinical neuroblastoma heterogeneity.
Rodriguez-Fos, Elias; Planas-Fèlix, Mercè; Burkert, Martin; Puiggròs, Montserrat; Toedling, Joern; Thiessen, Nina; Blanc, Eric; Szymansky, Annabell; Hertwig, Falk; Ishaque, Naveed; Beule, Dieter; Torrents, David; Eggert, Angelika; Koche, Richard P; Schwarz, Roland F; Haase, Kerstin; Schulte, Johannes H; Henssen, Anton G.
Afiliação
  • Rodriguez-Fos E; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Planas-Fèlix M; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Burkert M; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Puiggròs M; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Toedling J; Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • Thiessen N; Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center - Center for Genomic Regulation - Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain.
  • Blanc E; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Szymansky A; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany.
  • Hertwig F; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany.
  • Ishaque N; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Beule D; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Torrents D; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany.
  • Eggert A; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Digital Health Center, Berlin, Germany.
  • Koche RP; Barcelona Supercomputing Center, Joint Barcelona Supercomputing Center - Center for Genomic Regulation - Institute for Research in Biomedicine Research Program in Computational Biology, Barcelona, Spain.
  • Schwarz RF; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Haase K; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Schulte JH; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Henssen AG; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Cell Genom ; 3(10): 100402, 2023 Oct 11.
Article em En | MEDLINE | ID: mdl-37868040
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article